日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception

对人和小鼠肺腺癌前体细胞的空间和多组学分析表明,TIM-3 是癌前阻断的潜在靶点。

Bo Zhu ,Pingjun Chen ,Muhammad Aminu ,Jian-Rong Li ,Junya Fujimoto ,Yanhua Tian ,Lingzhi Hong ,Hong Chen ,Xin Hu ,Chenyang Li ,Natalie Vokes ,Andre L Moreira ,Don L Gibbons ,Luisa M Solis Soto ,Edwin Roger Parra Cuentas ,Ou Shi ,Songhui Diao ,Jie Ye ,Frank R Rojas ,Eduardo Vilar ,Anirban Maitra ,Ken Chen ,Nicolas Navin ,Monique Nilsson ,Beibei Huang ,Simon Heeke ,Jianhua Zhang ,Cara L Haymaker ,Vamsidhar Velcheti ,Daniel H Sterman ,Veena Kochat ,William I Padron ,Ludmil B Alexandrov ,Zhubo Wei ,Xiuning Le ,Linghua Wang ,Junya Fukuoka ,J Jack Lee ,Ignacio I Wistuba ,Harvey I Pass ,Mark Davis ,Samir Hanash ,Chao Cheng ,Steven Dubinett ,Avrum Spira ,Kunal Rai ,Scott M Lippman ,P Andrew Futreal ,John V Heymach ,Alexandre Reuben ,Jia Wu ,Jianjun Zhang

Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer

选择性可操作基因组改变对可切除非小细胞肺癌新辅助免疫治疗疗效的影响

Nicolas Zhou, Cheuk H Leung, William N William Jr, Annikka Weissferdt, Apar Pataer, Myrna C B Godoy, Brett W Carter, Frank V Fossella, Anne S Tsao, George R Blumenschein, Xiuning Le, Jianjun Zhang, Ferdinandos Skoulidis, Jonathan M Kurie, Mehmet Altan, Charles Lu, Bonnie S Glisson, Lauren A Byers, Y

CoCo-ST: Comparing and Contrasting Spatial Transcriptomics data sets using graph contrastive learning

CoCo-ST:使用图形对比学习比较和对比空间转录组学数据集

Muhammad Aminu, Bo Zhu, Natalie Vokes, Hong Chen, Lingzhi Hong, Jianrong Li, Junya Fujimoto, Yuqui Yang, Tao Wang, Bo Wang, Alissa Poteete, Monique B Nilsson, Xiuning Le, Cascone Tina, David Jaffray, Nick Navin, Lauren A Byers, Don Gibbons, John Heymach, Ken Chen, Chao Cheng, Jianjun Zhang, Jia Wu2

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

新辅助化疗联合纳武利尤单抗(加或不加伊匹木单抗)治疗可手术切除的非小细胞肺癌:NEOSTAR II期平台试验

Tina Cascone ,Cheuk H Leung ,Annikka Weissferdt ,Apar Pataer ,Brett W Carter ,Myrna C B Godoy ,Hope Feldman ,William N William Jr ,Yuanxin Xi ,Sreyashi Basu ,Jing Jing Sun ,Shalini S Yadav ,Frank R Rojas Alvarez ,Younghee Lee ,Aditya K Mishra ,Lili Chen ,Monika Pradhan ,Haiping Guo ,Ansam Sinjab ,Nicolas Zhou ,Marcelo V Negrao ,Xiuning Le ,Carl M Gay ,Anne S Tsao ,Lauren Averett Byers ,Mehmet Altan ,Bonnie S Glisson ,Frank V Fossella ,Yasir Y Elamin ,George Blumenschein Jr ,Jianjun Zhang ,Ferdinandos Skoulidis ,Jia Wu ,Reza J Mehran ,David C Rice ,Garrett L Walsh ,Wayne L Hofstetter ,Ravi Rajaram ,Mara B Antonoff ,Junya Fujimoto ,Luisa M Solis ,Edwin R Parra ,Cara Haymaker ,Ignacio I Wistuba ,Stephen G Swisher ,Ara A Vaporciyan ,Heather Y Lin ,Jing Wang ,Don L Gibbons ,J Jack Lee ,Nadim J Ajami ,Jennifer A Wargo ,James P Allison ,Padmanee Sharma ,Humam Kadara ,John V Heymach # ,Boris Sepesi #

CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance

CD70是EMT相关EGFR酪氨酸激酶抑制剂耐药中上调的治疗靶点。

Monique B Nilsson ,Yan Yang ,Simon Heeke ,Sonia A Patel ,Alissa Poteete ,Hibiki Udagawa ,Yasir Y Elamin ,Cesar A Moran ,Yukie Kashima ,Thiruvengadam Arumugam ,Xiaoxing Yu ,Xiaoyang Ren ,Lixia Diao ,Li Shen ,Qi Wang ,Minying Zhang ,Jacqulyne P Robichaux ,Chunhua Shi ,Allyson N Pfeil ,Hai Tran ,Don L Gibbons ,Jason Bock ,Jing Wang ,John D Minna ,Susumu S Kobayashi ,Xiuning Le ,John V Heymach

IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

IL6介导EMT相关TKI耐药EGFR突变型非小细胞肺癌中T细胞和NK细胞功能的抑制

Sonia A Patel ,Monique B Nilsson ,Yan Yang ,Xiuning Le ,Hai T Tran ,Yasir Y Elamin ,Xiaoxing Yu ,Fahao Zhang ,Alissa Poteete ,Xiaoyang Ren ,Li Shen ,Jing Wang ,Seyed Javad Moghaddam ,Tina Cascone ,Michael Curran ,Don L Gibbons ,John V Heymach

Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity

波齐替尼治疗EGFR 20号外显子突变型非小细胞肺癌:临床疗效、耐药机制及插入位点对药物敏感性的影响

Yasir Y Elamin ,Jacqulyne P Robichaux ,Brett W Carter ,Mehmet Altan ,Hai Tran ,Don L Gibbons ,Simon Heeke ,Frank V Fossella ,Vincent K Lam ,Xiuning Le ,Marcelo V Negrao ,Monique B Nilsson ,Anisha Patel ,R S K Vijayan ,Jason B Cross ,Jianjun Zhang ,Lauren A Byers ,Charles Lu ,Tina Cascone ,Lei Feng ,Rajyalakshmi Luthra ,Francis A San Lucas ,Geeta Mantha ,Mark Routbort ,George Blumenschein Jr ,Anne S Tsao ,John V Heymach

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

可手术非小细胞肺癌新辅助治疗:纳武利尤单抗或纳武利尤单抗联合伊匹木单抗:NEOSTAR II期随机试验

Tina Cascone ,William N William Jr ,Annikka Weissferdt ,Cheuk H Leung ,Heather Y Lin ,Apar Pataer ,Myrna C B Godoy ,Brett W Carter ,Lorenzo Federico ,Alexandre Reuben ,Md Abdul Wadud Khan ,Hitoshi Dejima ,Alejandro Francisco-Cruz ,Edwin R Parra ,Luisa M Solis ,Junya Fujimoto ,Hai T Tran ,Neda Kalhor ,Frank V Fossella ,Frank E Mott ,Anne S Tsao ,George Blumenschein Jr ,Xiuning Le ,Jianjun Zhang ,Ferdinandos Skoulidis ,Jonathan M Kurie ,Mehmet Altan ,Charles Lu ,Bonnie S Glisson ,Lauren Averett Byers ,Yasir Y Elamin ,Reza J Mehran ,David C Rice ,Garrett L Walsh ,Wayne L Hofstetter ,Jack A Roth ,Mara B Antonoff ,Humam Kadara ,Cara Haymaker ,Chantale Bernatchez ,Nadim J Ajami ,Robert R Jenq ,Padmanee Sharma ,James P Allison ,Andrew Futreal ,Jennifer A Wargo ,Ignacio I Wistuba ,Stephen G Swisher ,J Jack Lee ,Don L Gibbons ,Ara A Vaporciyan ,John V Heymach # ,Boris Sepesi #

Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target

EGFR突变型非小细胞肺癌免疫图谱分析揭示CD73/腺苷通路是潜在的治疗靶点

Xiuning Le ,Marcelo V Negrao ,Alexandre Reuben ,Lorenzo Federico ,Lixia Diao ,Daniel McGrail ,Monique Nilsson ,Jacqulyne Robichaux ,Irene Guijarro Munoz ,Sonia Patel ,Yasir Elamin ,You-Hong Fan ,Won-Chul Lee ,Edwin Parra ,Luisa Maren Solis Soto ,Runzhe Chen ,Jun Li ,Tatiana Karpinets ,Roohussaba Khairullah ,Humam Kadara ,Carmen Behrens ,Boris Sepesi ,Ruiping Wang ,Mingrui Zhu ,Linghua Wang ,Ara Vaporciyan ,Jack Roth ,Stephen Swisher ,Cara Haymaker ,Jianhua Zhang ,Jing Wang ,Kwok-Kin Wong ,Lauren A Byers ,Chantale Bernatchez ,Jianjun Zhang ,Ignacio I Wistuba ,Don L Gibbons ,Esra A Akbay ,John V Heymach

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity

泛癌图谱和ERBB2突变分析表明,Poziotinib是一种具有临床活性的T-DM1活性抑制剂和增强剂。

Jacqulyne P Robichaux ,Yasir Y Elamin ,R S K Vijayan ,Monique B Nilsson ,Lemei Hu ,Junqin He ,Fahao Zhang ,Marlese Pisegna ,Alissa Poteete ,Huiying Sun ,Shuai Li ,Ting Chen ,Han Han ,Marcelo Vailati Negrao ,Jordi Rodon Ahnert ,Lixia Diao ,Jing Wang ,Xiuning Le ,Funda Meric-Bernstam ,Mark Routbort ,Brent Roeck ,Zane Yang ,Victoria M Raymond ,Richard B Lanman ,Garrett M Frampton ,Vincent A Miller ,Alexa B Schrock ,Lee A Albacker ,Kwok-Kin Wong ,Jason B Cross ,John V Heymach